Cure Today1d
Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
MedPage Today3d
CAR-T Warning for Secondary Malignancies: Warranted or Not?
Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor ...
Cure Today4d
CAR T-Cell Therapy Yescarta Continues to Demonstrate Durable Responses in Follicular Lymphoma
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in ...